PHYTOSPAGYRIE N°13 CŒUR ET VAISSEAUX
Food supplement declared in France, declaration No 2018-10-631
PHYTOSPAGYRIE N°13 CŒUR ET VAISSEAUX (HERBIER DU VELAY) is a food supplement declared in France. Status: withdrawn from the market on 19 January 2023. Main ingredients: Juglans regia 600 mg per day, Melilotus officinalis 375 mg per day, Olea europaea 375 mg per day, Crataegus laevigata 150 mg per day. None of the rules we check flags an issue with its declared composition.
- Brand
- HERBIER DU VELAY
- Food business operator placing the product on the market
- SAS VECTEUR ENERGY
- Status
- Withdrawn from the market on 19 January 2023
- Form
- Bottle
- Daily dose
- 10
- Directions for use
- Prendre 5 ml (1 cuillère à café) matin et soir, à diluer dans 5 à 10 volumes d'eau. Agiter avant uti
- Not recommended (according to the manufacturer)
- Pregnant women
Declaration 210248, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Juglans regia L. | Parties aériennes | Macérât hydroglycériné | 600 mg |
| Melilotus officinalis (L.) Pall. | Parties aériennes | Macérât hydroglycériné | 375 mg |
| Olea europaea subsp. europaea | Feuille | Macérât hydroglycériné | 375 mg |
| Crataegus laevigata (Poir.) DC. | Sommités fleuries | Macérât hydroglycériné | 150 mg |
Additives
E422
Other ingredients
Vitis vinifera L.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
L'emploi du Mélilot est déconseillé aux femmes enceintes.
Regulatory points
- Information
Withdrawn from the market on 19 January 2023, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Olea europaea subsp. europaea
Read the warning, when it applies and the studies cited
OLIVE LEAF - OLEA EUROPAEA
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you pregnant or breastfeeding (EMA 2017).
Sources cited by Health Canada (1)
- EMA 2017: European Medicines Agency. European Union herbal monograph on Olea europaea L., folium. [Accessed 2024 November 27]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-olea-europaea-l-folium-first-version_en.pdf
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a kidney disorder (EMA 2017).
Sources cited by Health Canada (1)
- EMA 2017: European Medicines Agency. European Union herbal monograph on Olea europaea L., folium. [Accessed 2024 November 27]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-olea-europaea-l-folium-first-version_en.pdf
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking other diuretics (EMA 2017).
Sources cited by Health Canada (1)
- EMA 2017: European Medicines Agency. European Union herbal monograph on Olea europaea L., folium. [Accessed 2024 November 27]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-olea-europaea-l-folium-first-version_en.pdf
Known adverse reactions
Condition of application: All products except those making a diuretic claim.
When using this product diuretic effect may occur.
- Crataegus laevigata (Poir.) DC.
Read the warning, when it applies and the studies cited
Hawthorn
Route of administration: Oral (ESCOP 2009; Bradley 2006; Mills and Bone 2000)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking cardiac glycosides (e.g., digoxin) or blood pressure or heart medications (Brinker 2010; Bradley 2006).
Sources cited by Health Canada (2)
- Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (GB): British Herbal Medicine Association; 2006.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have chest pain, irregular heartbeat, or shortness of breath.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : HERBIER DU VELAY
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “PHYTOSPAGYRIE N°13 CŒUR ET VAISSEAUX (HERBIER DU VELAY): composition and regulation”, https://compoatlas.com/en/supplements/products/210248-phytospagyrie-n-13-c-ur-et-vaisseaux, updated 15 November 2026.